A comparison of four fully automated platforms for the measurement of plasma <i>p</i> ‐tau217 in the Alzheimer’s disease continuum

Fully automated immunoassays are essential for the widespread adoption of p -tau217, but they must uphold high diagnostic performances previously shown and recommended<sup>2</sup>. This study demonstrates four fully automated RUO assays exhibit comparable and desirable diagnostic accuracy for amyloid PET positivity. Further results will present findings from the full cohort (n =5,574), compare assays in terms of longitudinal change and relation to neuropathological change at post-mortem.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2025-12-01
DOI
https://doi.org/10.1002/alz70861_108882
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A comparison of four fully automated platforms for the measurement of plasma p ‐tau217 in the Alzheimer’s disease continuum

Tainá M. Marques, Nicholas James Ashton, Zivjena Vucetic, Rachael E. Wilson et al.
Alzheimer s & Dementia
Dementia and Cognitive Impairment Research
article

A comparison of four fully automated platforms for the measurement of plasma p ‐tau217 in the Alzheimer’s disease continuum

Tainá M. Marques, Nicholas James Ashton, Zivjena Vucetic, Rachael E. Wilson, Kinal Bhatt, EM Reiman, Arejas J. Uzgiris, Jessica B. Langbaum, Corey M. Carlson, Ramiro Eduardo Rea Reyes, Marisa N. Denkinger, R. A. Sperling, A. Atri, KA Johnson, Maria‐Magdalena Patru, Eddine Merabet, Valentina Ghisays, Paul S. Aisen, Geidy E Serrano, Alpana Singh, Kari Dieckhoff, James Liu, Elizabeth Head, Antoine Leuzy, Robert C. Alexander, Thomas G. Beach, Sterling C. Johnson
article en

Abstract

Fully automated immunoassays are essential for the widespread adoption of p -tau217, but they must uphold high diagnostic performances previously shown and recommended<sup>2</sup>. This study demonstrates four fully automated RUO assays exhibit comparable and desirable diagnostic accuracy for amyloid PET positivity. Further results will present findings from the full cohort (n =5,574), compare assays in terms of longitudinal change and relation to neuropathological change at post-mortem.

Alzheimer s & DementiaVol. 21(S7)
University of Southern California (US), Brigham and Women's Hospital (US), Roche (United States) (US), University of Wisconsin–Madison (US), Harvard University (US), University of California, Irvine (US), Massachusetts General Hospital (US), Banner Sun Health Research Institute (US), Beckman Coulter Foundation (US), Siemens Healthcare (United States) (US), Banner Alzheimer’s Institute
Openalex Percentile: Top 35%
Dementia and Cognitive Impairment Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.